WHO ARE WE?
ROPU MIDI is a Regional Operating Unit that covers all local Human Pharma and Animal Health Operating Units across Belgium, Denmark, Norway, Finland, Greece, Portugal, Sweden, and The Netherlands. MIDI has a multicultural and diverse work environment. More than 1.800 employees are striving to work together to improve lives for patients and animals in our region.
THE OPPORTUNITY
Are you energized by working across countries, functions, and stakeholders to bring innovative treatment options to patients? Join our team and play a key role in coordinating Early Access Treatment programs across the region, ensuring seamless execution, compliance, and patient-focused outcomes.
The Early Access Treatment Coordinator (EATC) MIDI is responsible for coordinating and executing the day-to-day activities related to Early Access Treatments (EAT) across the MIDI ROPU (Regional Operating Unit). This includes creation and filing of relevant documents in collaboration with the OPUs (Operating Units) and tracking all required parameters in the relevant systems.
The EATC MIDI is responsible for setting up effective and efficient collaboration, for internal and external program communication, and for program execution and for documentation and tracking thereof at MIDI level for individual EAT programs
Furthermore, the role supports localization of the relevant core documents and creation of required local documents for regulatory submission (if needed) in collaboration with MIDI stakeholders.
This position is based in Amsterdam and reports directly to the Medicine Operations Manager MIDI.
Please note that a 1-year fixed term contract initially will be offered.
HOW YOU’LL FIT IN:
YOU BRING:
WHAT WILL YOU GET IN RETURN?
Next to working in a Global Top Employer certified company that offers you the opportunity to develop and challenge yourself while learning from a fast-paced environment of our European MIDI region:
Please note that pay information will be shared during the recruitment process.
What’s next?
Please submit your application before 18th November 2026. We will have a look at your CV and cover letter. If we see a match, we will invite you for a video call interview to get to know each other. We will keep you posted during the process!
Screening:
In order to comply with applicable export control laws, Boehringer Ingelheim periodically screens business relations (including job applicants) against sanctioned party lists (“SPL”). These checks may be performed by Boehringer Ingelheim or by any of its Affiliates. You acknowledge that Boehringer Ingelheim and/or its Affiliates will screen you against SPL and that for this purpose your personal data may be processed in relevant databases, including databases of third-party vendors that perform SPL screening for or on behalf of Boehringer Ingelheim or its Affiliates which may be located or accessible outside the EU. Boehringer Ingelheim is committed to ensuring an adequate level of protection of your personal data.
Boehringer Ingelheim
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead...
Read more about the companyCopyright © 2026 Grabjobs Pte.Ltd. All Rights Reserved.